DDrare: Database of Drug Development for Rare Diseases

Cdx-1135 (DrugBank: -)

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
222	一次性ネフローゼ症候群	1
223	一次性膜性増殖性糸球体腎炎	1

222. 一次性ネフローゼ症候群　［臨床試験数：234，薬物数：241（DrugBank：78），標的遺伝子数：59，標的パスウェイ数：185］

Searched query = "Primary nephrotic syndrome", "Minimal change nephrotic syndrome", "MCNS", "Membranous nephropathy", "Focal segmental glomerulosclerosis", "FSGS", "Membranoproliferative glomerulonephritis", "MPGN"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 234 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01791686 (ClinicalTrials.gov)	January 2013	29/1/2013	Clinical Trial of CDX-1135 in Pediatric and Adult Patients With Dense Deposit Disease	A Pilot, Open-label, Multicenter Clinical Trial of CDX-1135 in Pediatric and Adult Patients With Dense Deposit Disease	Dense Deposit Disease;Membranoproliferative Glomerulonephritis Type II;C3 Glomerulonephritis	Drug: CDX-1135	Celldex Therapeutics	NULL	Terminated	4 Years	N/A	Both	1	Phase 1	United States

223. 一次性膜性増殖性糸球体腎炎　［臨床試験数：18，薬物数：14（DrugBank：7），標的遺伝子数：7，標的パスウェイ数：14］

Searched query = "Primary membranoproliferative glomerulonephritis", "Dense deposit disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 18 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01791686 (ClinicalTrials.gov)	January 2013	29/1/2013	Clinical Trial of CDX-1135 in Pediatric and Adult Patients With Dense Deposit Disease	A Pilot, Open-label, Multicenter Clinical Trial of CDX-1135 in Pediatric and Adult Patients With Dense Deposit Disease	Dense Deposit Disease;Membranoproliferative Glomerulonephritis Type II;C3 Glomerulonephritis	Drug: CDX-1135	Celldex Therapeutics	NULL	Terminated	4 Years	N/A	Both	1	Phase 1	United States